Search 

Pebmond Associates provides multifaceted board-level advisory, business development and licensing services. Operating in the EU, US and emerging markets we add value to clients by providing solutions for developing and growing pharma companies, including services from a network of trusted partner companies.

Pneumagen is focusing on the treatment and prevention of infectious diseases and the treatment of cancer using a first-in-class, directed approach that targets glycans. Our platform technology, GlycoTarge™, is generating glycan targeted carbohydrate binding modules (mCBMs), as a new therapeutic modality for the universal treatment and prevention of respiratory tract infections (influenza and RSV) and also as direct therapies in oncology.